VAN ECK ASSOCIATES CORP - MEDGENICS INC ownership

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of MEDGENICS INC
ValueSharesWeighting
Q3 2016$88,000
+1.1%
15,746
+0.4%
0.00%
Q2 2016$87,000
-1.1%
15,688
-21.5%
0.00%
-100.0%
Q1 2016$88,000
-26.7%
19,983
+0.6%
0.00%0.0%
Q4 2015$120,000
-13.0%
19,868
+13.0%
0.00%0.0%
Q3 2015$138,000
+46.8%
17,589
+14.7%
0.00%0.0%
Q2 2015$94,000
-30.9%
15,341
-9.0%
0.00%0.0%
Q1 2015$136,000
+49.5%
16,861
-6.7%
0.00%0.0%
Q4 2014$91,000
+18.2%
18,067
+21.5%
0.00%
Q3 2014$77,000
-26.7%
14,869
+10.2%
0.00%
Q2 2014$105,000
+34.6%
13,487
+21.2%
0.00%
Q1 2014$78,000
+47.2%
11,124
+26.2%
0.00%
Q4 2013$53,0008,8160.00%
Other shareholders
MEDGENICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Belmont Global Advisors, Inc. 163,347$848,0000.66%
CARL DOMINO INC 20,134$104,0000.06%
WHITE PINE CAPITAL LLC 20,000$104,0000.04%
Perceptive Advisors 55,073$286,0000.03%
WFG Advisors, LP 20,000$104,0000.02%
HYMAN CHARLES D 14,500$75,0000.01%
Spark Investment Management LLC 13,500$70,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 80,000$415,0000.01%
Baillie Gifford 360,650$1,872,0000.00%
Janney Montgomery Scott LLC 32,673$169,573,0000.00%
View complete list of MEDGENICS INC shareholders